knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 22:16:12 - browse：723

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： A disappointing year of Humira biosimilars

WSS

Key House Republican on health care plans exit from Congress

Helping hospitals and community health centers plan for resilience

With measles on the rise, a personal story of a devastating disease

PhRMA lawsuit over Medicare drug price negotiation tossed

Senators start work on Medicare physician payment reform

Anxious about a speech? A startup wants you to pop a minty cardiac drug

focus

knowledge

focus

Medicare details structure of new drug price negotiation program

Wearables generate powerful data but its not useful to doctors, yet

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Medical records are filled with copy

HIV vaccine remains elusive. Immunologists keep trying new ideas

Drug repurposing or repositioning? The language matters

Wearables generate powerful data but its not useful to doctors, yet

After affirmative action ruling, medical educators look to 'holistic review'

NVIDIA and Google execs on the future of AI and drug discovery

explore

比如在图文创业者这边，你大概不怎么听说有人花钱不做投放，只是让人写稿子。

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Vaccine advisory panel ACIP left half staffed by HHS

What we’ve learned from the Aduhelm mess

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

When prostate cancer spreads, where it goes matters

leisure time

focus

entertainment

Wikipedia